Chronic Diabetic Macular Oedema Considered Insufficiently Responsive to Available Therapies

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

ANI Pharmaceuticals
1 program
Iluvien Registry Safety StudyN/A1 trial
Active Trials
NCT01998412UnknownEst. Jan 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ANI PharmaceuticalsIluvien Registry Safety Study

Clinical Trials (1)

NCT01998412ANI PharmaceuticalsIluvien Registry Safety Study

Iluvien Registry Safety Study

Start: Dec 2013Est. completion: Jan 2020
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space